These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 23106878)
1. Androgen replacement therapy improves psychological distress and health-related quality of life in late onset hypogonadism patients in Chinese population. Zhang XW; Liu ZH; Hu XW; Yuan YQ; Bai WJ; Wang XF; Shen H; Zhao YP Chin Med J (Engl); 2012 Nov; 125(21):3806-10. PubMed ID: 23106878 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale. Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057 [TBL] [Abstract][Full Text] [Related]
3. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study. Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM; Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706 [TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report. Morrison BF; Reid M; Madden W; Burnett AL Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509 [TBL] [Abstract][Full Text] [Related]
5. Oral testosterone undecanoate (Andriol) supplement therapy improves the quality of life for men with testosterone deficiency. Park NC; Yan BQ; Chung JM; Lee KM Aging Male; 2003 Jun; 6(2):86-93. PubMed ID: 12898792 [TBL] [Abstract][Full Text] [Related]
6. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study). Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A; Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040 [TBL] [Abstract][Full Text] [Related]
7. [Androgen replacement therapy improves health-related quality of life in late onset hypogonadism patients]. Taniguchi H; Kawa G; Kinoshita H; Matsuda T Hinyokika Kiyo; 2009 Dec; 55(12):741-4. PubMed ID: 20048556 [TBL] [Abstract][Full Text] [Related]
8. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956 [TBL] [Abstract][Full Text] [Related]
9. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial. Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318 [TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials. Nian Y; Ding M; Hu S; He H; Cheng S; Yi L; Li Y; Wang Y Andrologia; 2017 May; 49(4):. PubMed ID: 27389320 [TBL] [Abstract][Full Text] [Related]
11. 12-month observation of testosterone replacement effectiveness in a general population of men. Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767 [TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS). Glaser R; York AE; Dimitrakakis C Maturitas; 2011 Apr; 68(4):355-61. PubMed ID: 21177051 [TBL] [Abstract][Full Text] [Related]
13. Testosterone and men's quality of life. Moncada I Aging Male; 2006 Dec; 9(4):189-93. PubMed ID: 17178553 [TBL] [Abstract][Full Text] [Related]
14. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism. Jungwirth A; Plas E; Geurts P Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of androgen replacement therapy in aging Japanese men with late-onset hypogonadism. Okada K; Yamaguchi K; Chiba K; Miyake H; Fujisawa M Aging Male; 2014 Jun; 17(2):72-5. PubMed ID: 24533913 [TBL] [Abstract][Full Text] [Related]
16. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433 [TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men. Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ J Androl; 1998; 19(6):761-8. PubMed ID: 9876028 [TBL] [Abstract][Full Text] [Related]
18. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels. Blick G Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769 [TBL] [Abstract][Full Text] [Related]
19. Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. Wang C; Alexander G; Berman N; Salehian B; Davidson T; McDonald V; Steiner B; Hull L; Callegari C; Swerdloff RS J Clin Endocrinol Metab; 1996 Oct; 81(10):3578-83. PubMed ID: 8855804 [TBL] [Abstract][Full Text] [Related]
20. Is discontinuation of hormone replacement therapy possible for patients with late-onset hypogonadism? Tsujimura A; Takada S; Matsuoka Y; Hirai T; Takao T; Miyagawa Y; Nonomura N; Okuyama A Int J Urol; 2008 Jul; 15(7):625-9. PubMed ID: 18479356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]